Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2017OncogeneOpen Access

Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBrandyn CastroNorthwestern MedicinePFPatrick M. FlaniganMayo ClinicAJArman JahangiriUniversity of Miami

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Castro et al. (2017) studied this question.

synapsesocial.com/papers/6a18ccdb673175fe754aec13https://doi.org/10.1038/onc.2017.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy2012 · 114 citations
  2. 2Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes2014 · 81 citations
  3. 3Anti-VEGF Antibody Treatment of Glioblastoma Prolongs Survival But Results in Increased Vascular Cooption2000 · 512 citations
  4. 4<scp>MIF</scp> Receptor <scp>CD</scp>74 is Restricted to Microglia/Macrophages, Associated with a <scp>M</scp>1‐Polarized Immune Milieu and Prolonged Patient Survival in Gliomas2014 · 109 citations
  5. 5Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance2013 · 204 citations